Journal of Biomolecular Screening 2013-01-01

Use of escin as a perforating agent on the IonWorks quattro automated electrophysiology platform.

Michael J Morton, Martin J Main

Index: J. Biomol. Screen. 18(1) , 128-34, (2013)

Full Text: HTML

Abstract

The automated electrophysiology platform IonWorks has facilitated the medium-throughput study of ion channel biology and pharmacology. Electrical and chemical access to the cell is by perforated patch, afforded by amphotericin. Permeation of the amphotericin pore is limited to monovalent cations. We describe here the use of the saponin escin as an alternative perforating agent. With respect to the number and robustness of seals formed across a variety of cell and ion channel types, the performance of escin is equal to that of amphotericin. Escin also permits the permeation of larger molecules through its pore. These include nucleotides, important intracellular modulators of ion channel activity that can be used to prevent ion channel rundown of, for instance, Ca(V)1.2. Furthermore, pharmacologic agents such as QX314 can also permeate and be used for mechanistic studies. Escin, in combination with IonWorks, increases the scope of ion channel screening and can facilitate the assay of previously difficult-to-assay targets.


Related Compounds

  • Escin
  • Lidocaine N-ethyl...

Related Articles:

Effect of beta-aescin extract from Chinese buckeye seed on chronic venous insufficiency.

2013-06-01

[Pharmazie 68(6) , 428-30, (2013)]

Interaction between titanium and cadmium in various guinea pig organs.

2013-02-01

[Biol. Trace Elem. Res. 151(2) , 209-16, (2013)]

Rho-kinase inhibition attenuates calcium-induced contraction in β-escin but not Triton X-100 permeabilized rabbit femoral artery.

2011-09-01

[J. Muscle Res. Cell Motil. 32(2) , 77-88, (2011)]

Bioavailability of l-thyroxine and its metabolites after topical treatment with an emulsion containing 0.1% micronised l-thyroxine.

2013-06-01

[G. Ital. Dermatol. Venereol. 148(3) , 287-92, (2013)]

[Efficacy of the anti-edema drug L-lysine aescinat in stroke].

2012-01-01

[Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 112(12 Pt 2) , 31-4, (2012)]

More Articles...